Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

With solo travel bigger than ever, Globus and Cosmos have hopped on the trend with Globus completely waiving the single supplement fee off select Globus Escapes Europe tours, while Cosmos is offering ...

StockNews.com upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research ...

Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the ...

Quarterly Net Profit at Rs. 0.72 crore in December 2024 down 98.38% from Rs. 44.54 crore in December 2023. EBITDA stands at ...

State of Alaska Department of Revenue reduced its stake in shares of Globus Medical, Inc. (NYSE:GMED – Free Report) by 1.2% ...

Globus Spirits Ltd (BOM:533104) reports robust consumer business growth amid manufacturing challenges and strategic market expansions.

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Penumbra (PEN – Research Report), with a price target of ...

BTIG analyst Ryan Zimmerman maintained a Hold rating on Tactile Systems Technology (TCMD – Research Report) yesterday. The company’s shares ...

A new study led by recent undergraduate student Caitlyn Nojiri and co-authored by astronomy and astrophysics professor Enrico ...

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.